With 2.22 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.12 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $408.51 whereas the lowest price it dropped to was $394.12. The 52-week range on HCA shows that it touched its highest point at $417.14 and its lowest point at $215.96 during that stretch. It currently has a 1-year price target of $414.64. With its current market cap of 102.94 billion, HCA has annualized dividend of $2.58 while the current yield stands at 0.65%. Beta for the stock currently stands at 1.67.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HCA was down-trending over the past week, with a drop of -1.86%, but this was down by -1.53% over a month. Three-month performance surged to 12.44% while six-month performance rose 26.99%. The stock gained 73.34% in the past year, while it has gained 47.37% so far this year. A look at the trailing 12-month EPS for HCA yields 21.31 with Next year EPS estimates of 24.96. For the next quarter, that number is 4.96. This implies an EPS growth rate of 18.28% for this year and 11.00% for next year. EPS is expected to grow by 12.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 12.21%.
Float and Shares Shorts:
At present, 265.54 million HCA shares are outstanding with a float of 185.65 million shares on hand for trading. On 2024-09-30, short shares totaled 2.68 million, which was 104.0 higher than short shares on 1724976000. In addition to Mr. Samuel N. Hazen as the firm’s CEO & Director, Mr. Jon Mack Foster serves as its Executive VP & COO.
Institutional Ownership:
Through their ownership of 0.64499 of HCA’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, HCA reported revenue of $17492000000.0 and operating income of $2731000000.0. The EBITDA in the recently reported quarter was $3550000000.0 and diluted EPS was $5.53.